{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:54:29Z","timestamp":1793058869506,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010115","name":"Auvergne-Rh\u00f4ne-Alpes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010115","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nouvelle-Aquitaine Regional Health Agencies"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.psychres.2019.112543","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T19:39:01Z","timestamp":1567021141000},"page":"112543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Functioning and cognitive characteristics of clozapine users referred to psychosocial rehabilitation centers: A REHABase cohort study"],"prefix":"10.1016","volume":"281","author":[{"given":"H\u00e9l\u00e8ne","family":"VERDOUX","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9lia","family":"QUILES","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"CERVELLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"DUBREUCQ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"BON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"MASSOUBRE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"POMMIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"LEGROS-LAFARGE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nemat","family":"JAAFARI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"GUILLARD-BOUHET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"CH\u00c9REAU-BOUDET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"COUHET","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"PLASSE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"FRANCK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2019.112543_bib0001","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.psychres.2019.112543_bib0002","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.psychres.2019.112543_bib0003","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/j.1440-1614.2006.01921.x","article-title":"Stages of recovery instrument: development of a measure of recovery from serious mental illness","volume":"40","author":"Andresen","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.euroneuro.2017.12.006","article-title":"Clozapine use in patients with schizophrenia and a comorbid substance use disorder: a systematic review","volume":"28","author":"Arranz","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.112543_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.112543_bib0006","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/appi.ajp.161.2.364","article-title":"Do clozapine and risperidone affect social competence and problem solving?","volume":"161","author":"Bellack","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0447.1994.tb01487.x","article-title":"A self-report insight scale for psychosis: reliability, validity and sensitivity to change","volume":"89","author":"Birchwood","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.112543_bib0008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/JCP.0000000000000478","article-title":"Clozapine underutilization in the treatment of schizophrenia how can clozapine prescription rates be improved?","volume":"36","author":"Bogers","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112543_bib0009","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1176\/appi.ajp.2012.11091337","article-title":"Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior","volume":"169","author":"Bowie","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2010.05.019","article-title":"The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia","volume":"121","author":"Boyer","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.112543_bib0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2010.09.001","article-title":"Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: the GAMIAN-Europe study","volume":"129","author":"Brohan","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2019.112543_bib0012","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/appi.ps.201500493","article-title":"An initiative to improve clozapine prescribing in New York State","volume":"67","author":"Carruthers","year":"2016","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2019.112543_bib0013","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17512433.2019.1577134","article-title":"A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults","volume":"12","author":"Cicala","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2019.112543_bib0014","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s40263-017-0481-5","article-title":"Clozapine and gastrointestinal hypomotility","volume":"31","author":"Cohen","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2019.112543_bib0015","unstructured":"Fournier, N., Demazieres-Pelletier, Y., Favier, S., Lemoine, L., Gros, C., 2015. Test de commissions r\u00e9vis\u00e9. GREMOIRE 2. Tests et \u00e9chelles des maladies neurologiques avec symptomatologie cognitive. De Boeck Solal, eds, Belgium."},{"key":"10.1016\/j.psychres.2019.112543_bib0016","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1176\/appi.ps.201800420","article-title":"Satisfaction and needs in serious mental illness and autism spectrum disorder: the REHABase psychosocial rehabilitation project","volume":"70","author":"Franck","year":"2019","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2019.112543_bib0017","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.schres.2013.03.009","article-title":"Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial","volume":"147","author":"Franck","year":"2013","journal-title":"Schizophr. Res."},{"issue":"Suppl 2","key":"10.1016\/j.psychres.2019.112543_bib0018","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.14074su1c.02","article-title":"Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia","volume":"77","author":"Green","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0019","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \"right stuff\"?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112543_bib0020","series-title":"ECDEU Assessment Manual For Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.psychres.2019.112543_bib0021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/YIC.0000000000000066","article-title":"Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics","volume":"30","author":"Han","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112543_bib0022","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-Resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0023","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","article-title":"A systematic review and meta-analysis of recovery in schizophrenia","volume":"39","author":"Jaaskelainen","year":"2013","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.psychres.2019.112543_bib0024","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.psychres.2009.04.001","article-title":"Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment","volume":"178","author":"Kaneda","year":"2010","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.psychres.2019.112543_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112543_bib0026","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/JCP.0000000000000649","article-title":"Predictors of nonhospitalization and functional response in clozapine treatment: a nationwide, population-based cohort study","volume":"37","author":"Kohler-Forsberg","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112543_bib0027","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.euroneuro.2014.08.003","article-title":"Relationship between clinical improvement and functional gains with clozapine in schizophrenia","volume":"24","author":"Lee","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.112543_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5498\/wjp.v8.i1.1","article-title":"Promoting recovery from severe mental illness: implications from research on metacognition and metacognitive reflection and insight therapy","volume":"8","author":"Lysaker","year":"2018","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0029","series-title":"Le Test Des commissions. Epreuve d'adaptation m\u00e9thodique","author":"Martin","year":"1972"},{"key":"10.1016\/j.psychres.2019.112543_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112543_bib0031","first-page":"409","article-title":"[Therapeutic adherence and schizophrenia: the interest of the validation of the French translation of Medication Adherence Rating Scale (MARS)]","volume":"30","author":"Misdrahi","year":"2004","journal-title":"Encephale"},{"key":"10.1016\/j.psychres.2019.112543_bib0032","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0447.2011.01710.x","article-title":"Optimizing clozapine treatment","volume":"123","author":"Nielsen","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.112543_bib0033","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s40263-018-0565-x","article-title":"Clozapine and psychosocial function in schizophrenia: a systematic review and meta-analysis","volume":"32","author":"Olagunju","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2019.112543_bib0034","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.schres.2005.03.001","article-title":"Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program","volume":"77","author":"Prouteau","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.112543_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0706743716656830","article-title":"From clozapine to cognitive remediation","volume":"62","author":"Quinn","year":"2017","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.psychres.2003.08.008","article-title":"Internalized stigma of mental illness: psychometric properties of a new measure","volume":"121","author":"Ritsher","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2019.112543_bib0037","series-title":"Society and the Adolacent Self-Image","author":"Rosenberg","year":"1965"},{"key":"10.1016\/j.psychres.2019.112543_bib0038","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/archpsyc.55.7.618","article-title":"Does participation in psychosocial treatment augment the benefit of clozapine? department of veterans affairs cooperative study group on clozapine in refractory schizophrenia","volume":"55","author":"Rosenheck","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0039","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0040","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0706743717718167","article-title":"Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis","volume":"62","author":"Siskind","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0041","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2015.15030332","article-title":"Comparative effectiveness of clozapine and standard antipsychotic treatment in adults with schizophrenia","volume":"173","author":"Stroup","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0042","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/ajp.2007.164.3.428","article-title":"Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study","volume":"164","author":"Swartz","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0043","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1477-7525-5-63","article-title":"The Warwick-Edinburgh Mental Well-Being Scale (WEMWBS): development and UK validation","volume":"5","author":"Tennant","year":"2007","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.psychres.2019.112543_bib0044","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","article-title":"Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses","volume":"42","author":"Thompson","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.112543_bib0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.psychres.2016.08.050","article-title":"Validation of the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) in French psychiatric and general populations","volume":"245","author":"Trousselard","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2019.112543_bib0046","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/00207599008247865","article-title":"Traduction et validation canadienne fran\u00e7aise de l\u2019\u00e9chelle de l'estime de soi de Rosenberg","volume":"25","author":"Vallieres","year":"1990","journal-title":"Int. J. Psychol."},{"key":"10.1016\/j.psychres.2019.112543_bib0047","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbx088","article-title":"The relationship between clinical and personal recovery in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis","volume":"44","author":"Van Eck","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112543_bib0048","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/acps.12344","article-title":"Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample","volume":"130","author":"Verdoux","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.112543_bib0049","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2018.05.046","article-title":"Prescriber and institutional barriers and facilitators of clozapine use: a systematic review","volume":"201","author":"Verdoux","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2019.112543_bib0050","doi-asserted-by":"crossref","unstructured":"Vermeulen, J.M., van Rooijen, G., van de Kerkhof, M.P.J., Sutterland, A.L., Correll, C.U., de Haan, L., 2019. Clozapine and long-term mortality risk in patients with schizophrenia: aA systematic review and meta-analysis of studies lasting 1.1\u201312.5 Years. Schizophr Bull 45, 315-329. 10.1093\/schbul\/sby052.","DOI":"10.1093\/schbul\/sby052"},{"key":"10.1016\/j.psychres.2019.112543_bib0051","series-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.psychres.2019.112543_bib0052","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1176\/appi.ajp.2017.16091097","article-title":"Mortality and self-harm in association with clozapine in treatment-resistant schizophrenia","volume":"174","author":"Wimberley","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112543_bib0053","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2019.112543_bib0054","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/schbul\/sbn143","article-title":"Clinical recovery in first-episode psychosis","volume":"35","author":"Wunderink","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2019.112543_bib0055","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1176\/appi.ajp.2010.10060855","article-title":"A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes","volume":"168","author":"Wykes","year":"2011","journal-title":"Am. J. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811931457X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811931457X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:33:57Z","timestamp":1759037637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811931457X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":55,"alternative-id":["S016517811931457X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112543","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functioning and cognitive characteristics of clozapine users referred to psychosocial rehabilitation centers: A REHABase cohort study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112543"}}